Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20210925052566N1
IRCT20210925052566N1
Not yet recruiting
Phase 1

Transplantation of allogenic mesenchymal stem cells (MSCs) derived from placenta and adipose tissue for the treatment of type 1 diabetes mellitus (T1DM): a clinical trial, phase 1 and 2.

Endocrinology and Metabolism Research Institute0 sites30 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsType 1 diabetes mellitus (T1DM).Type 1 diabetes mellitus

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Type 1 diabetes mellitus (T1DM).
Sponsor
Endocrinology and Metabolism Research Institute
Enrollment
30
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Endocrinology and Metabolism Research Institute

Eligibility Criteria

Inclusion Criteria

  • •All adults (\= 18 year) with T1DM which diagnosis less than 1 year from the onset of diabetes
  • •Have at least one T1DM related autoantibody

Exclusion Criteria

  • •Inability to fill informed consent
  • •Pregnancy in women
  • •Having any chronic complication of diabetes including nephropathy, retinopathy and vascular complications
  • •Having a serious infection or have a positive test for hepatitis B, hepatitis C or HIV
  • •Having other chronic comorbidities such as psychological, cardiovascular, renal, pulmonary, liver, hematologic and other serious autoimmune diseases (except T1DM or Hashimoto's disease)
  • •History of cancer
  • •History of diabetic ketoacidosis

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Transplantation of Autologous Stem Cells for the treatment of corneal diseases
EUCTR2018-000523-14-ESniversidad Miguel Hernandez30
Completed
Not Applicable
Mesenchymal stem cell transplantation in the treatment of type 1 diabetic patientsType 1 diabetes.Insulin-dependent diabetes mellitus
IRCT138810271414N8Endocrinology & Metabolism Research Center20
Completed
Not Applicable
Clinical trial of mesenchymal stem cell transplantation for severe heart failureSevere chronic heart failure
JPRN-UMIN000000656ational Cardiovascular Center20
Active, not recruiting
Phase 1
The use of mesenchymal stem cells from the bone marrow stroma for reconstruction of the anterior cruciate ligament
EUCTR2020-002732-75-PLAlexander IV sp. Partnership Ortopedika Surgery Specialistic Center12
Withdrawn
Phase 2
Mesenchymal stromal cell (MSC) transplantation in septic shock.septisch shockseptic shock and severe blood poisoning1002766510002252
NL-OMON39173Erasmus MC, Universitair Medisch Centrum Rotterdam30